...
首页> 外文期刊>Child's nervous system: ChNS : official journal of the International Society for Pediatric Neurosurgery >Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients
【24h】

Lacosamide treatment of childhood refractory focal epilepsy: the first reported side effect in paediatric patients

机译:儿童难治性焦点癫痫的漆酰胺治疗:第一次报告的儿科患者副作用

获取原文
获取原文并翻译 | 示例
           

摘要

Lacosamide (LCM) is an effective antiepileptic drug (AED) approved for the treatment of focal epilepsy in both children and adults. The aim of this observational study was to review our centre's experience with LCM and to characterise its efficacy and tolerability as an adjunct therapy in children with refractory focal epilepsy.
机译:漆酰胺(LCM)是批准用于治疗儿童和成人局灶性癫痫的有效抗癫痫药物(AED)。 该观察项研究的目的是审查我们的中心的LCM经验,并将其疗效和耐受性表征为难治局灶性癫痫儿童的辅助治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号